Malignant progression in O6-methylguanine-DNA methyltransferase-deficient esophageal cancer cells is associated with Ezrin Protein

DNA and Cell Biology

Volumn 31, Issue 5, 2012, Pages 856-866

  Su, Yaoyao ^a   Liu, Ran ^a   Sheng, Jingyi ^a   Liu, Hui ^a   Wang, Yi ^b   Pan, Enchun ^b   Guo, Wei ^c   Pu, Yuepu ^a   Zhang, Juan ^a   Liang, Geyu ^a   Tang, Derong ^c   Yin, Lihong ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b Disease Control and Prevention Center of Huaian   (China)

^c THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; METHYLNITRONITROSOGUANIDINE; CYTOSKELETON PROTEIN; DRUG DERIVATIVE; GUANINE; MESSENGER RNA; O (6) METHYLGUANINE; O-(6)-METHYLGUANINE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL INVASION; CELL MOTILITY; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; IC 50; MALE; MALIGNANT TRANSFORMATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CHO CELL; DRUG ANTAGONISM; ESOPHAGUS; ESOPHAGUS TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; GENETICS; HAMSTER; METABOLISM; MUTATION; NUDE MOUSE; PATHOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CYTOSKELETAL PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FLUORESCENT ANTIBODY TECHNIQUE; GUANINE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MUTATION; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFECTION;

EID: 84861395447     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1318     Document Type: Article

References (43)

1. Akisawa, N., Nishimori, I., and Iwamura, T. (1999). High Levels of Ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun 258, 395-400. (Pubitemid 29287062)
2. Algrain, M., Turunen, O., Vaheri, A., and Arpin, M. (1993). Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol 120, 129-139.
3. Barch, D.H., Jacoby, R.F., Brasitus, T.A., Radosevich, J.A., Carney, W.P., and Iannaccone, P. (1991). Incidence of Harvey ras oncogene point mutations and their expression in methylbenzylnitrosamine-induced esophageal tumorigenesis. Carcinogenesis 12, 2373-2377.
4. Becker, K., Gregel, C., Fricke, C., Komitowski, D., Dosch, J., and Kaina, B. (2003). DNA repair protein MGMT protects against N-methyl-N-nitrosourea- induced conversion of benign into malignant tumors. Carcinogenesis 24, 541-546. (Pubitemid 36432651)
5. Bobola, M.S., Blank, A., Berger, M.S., and Silber, J.R. (2007). O6-methylguanine-DNA methyltransferase deficiency in developing brain: implications for brain tumorigenesis. DNA repair 6, 1127-1133. (Pubitemid 47058390)
6. Cullen, B.R. (2006). Induction of stable RNA interference in mammalian cells. Gene Ther 13, 503-508.
7. Domoradzki, J., Pegg, A.E., Dolan M.E., Maher, V.M., and McCormick, J.J. (1984). Correlation between O6-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N' -nitro-N-nitrosoguanidine. Carcinogenesis 5, 1641-1647. (Pubitemid 15127031)
8. Elbashir, S.M., Harborth, J., and Lendeckel, W. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498. (Pubitemid 32494397)
9. Elliott, B.E., Meens, J.A., SenGupta, S.K., Louvard, D., and Arpin, M. (2005). The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res 7, 365-373.
10. Esteller, M., Hamilton, S.R., Burger, P.C., Baylin, S.B., and Herman, J.G. (1999). Inactivation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase by Promoter Hypermethylation is a Common Event in Primary Human Neoplasia. Cancer Res 59, 793-797. (Pubitemid 29086728)
11. Fan, H.B., Guo, L.P., and Lu, S.X. (2010). Effects of Ezrin on invasion, motility and adhesion of esophageal squamous carcinoma cells. China Cancer 19, 266-269.
12. Gerson, S.L. (2004). MGMT: its role in cancer aetiology and cancer therapeutics. Nature Rev Cancer 4, 296-307. (Pubitemid 38525285)
13. Kaina, B., Christmann, M., Naumann, S., and Roos, W.P. (2007).MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair 6, 1079-1099. (Pubitemid 47058389)
14. Kato, T., Natsume, A., Toda, H., Iwamizu, H., Sugita, T., Hachisu, R., Watanabe, R., Yuki, K., Motomura, K., Bankiewicz, K., and Wakabayashi, T. (2010). Efficient delivery of liposomemediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells. Gene Ther 17, 1363-1371.
15. Kitajima, Y., Miyazaki, K., Matsukura, S., Tanaka, M., and Sekiguchi, M. (2003). Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer. Gastric Cancer 6, 86-95. (Pubitemid 36829962)
16. Khanna, C., Wan, X., Bose, S., Cassaday, R., Olomu, O., Mendoza, A., Yeung, C., Gorlick, R., Hewitt, S.M., and Helman, L.J. (2004). The embrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10, 182-186. (Pubitemid 38524889)
17. Kuester, D., Wa'el, E.R., Peng, D.F., Ruemmele, P., Kroeckel, I., Peters, B., Moskaluk, C.A., Stolte, M., Mönkemü ller, K., Meyer, F., Schulz, H.U., Hartmann, A., Roessner, A., and Schneider-Stock, R. (2009). Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia- carcinoma sequence of Barrett's esophagus. Cancer Lett 275, 117-126.
18. Liu, L.L., Qin, X.S., and Gerson, S.L. (1999). Reduced lung tumorigenesis in human methylguanine DNA-methyltransferase transgenic mice achieved by expression of transgene within the target cell. Carcinogenesis 20, 279-284. (Pubitemid 29057561)
19. Margison, G.P., Koref, M.F., and Povey, A.C. (2002). Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine. Mutagenesis 17, 483-487.
20. Mollemann, M., Wolter, M., Felsberg, J., Collins, P., and Reifenberger, G. (2005). Frequent promoter hypermethylation and low Expression of the MGMT Gene inoligodendroglial tumors. Int J Cancer 113, 379-385. (Pubitemid 40038704)
21. Nakagawachi, T., Soejima, H., Urano, T., Wei, Z., Higashimoto, K., Satoh, Y., Matsukura, S., Kudo, S., Kitajima, Y., Harada, H., Furukawa, K., Matsuzaki, H., Emi, M., Nakabeppu, Y., Miyazaki, K., Sekiguchi, M., and Mukai, T. (2003). Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene 22, 8835-8844. (Pubitemid 38021499)
22. Nakasu, S., Fukami, T., Jito, J., and Matsuda, M. (2007). Prognostic significance of loss of O6-methylguanine-DNA methyltransferase expression in supratentorial diffuse low-grade astrocytoma. Surg Neurol 68, 603-609.
23. Ohgaki, H., Hard, G.C., Hirota, N., Maekawa, A., Takahashi, M., and Kleihues, P. (1992). Selective mutation of codons 204 and 213 of the p53 gene in rat tumors induced by alkylating N-nitroso compounds. Cancer Res 52, 2995-2998.
24. Oh, K., Redston, M., and Odze, R.D. (2005) Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol 36, 101-111. (Pubitemid 40215639)
25. Olsson, M., and Lindahl, T. (1980). Repair of Alkylated DNA in Escherichia coli: methyl group transfer from O6-methylguanine to a protein cysteine residue. J Biol Chem 255, 10569-10571. (Pubitemid 11171712)
26. Sawhney,M., Rohatgi,N., Kaur, J.,Gupta, S.D.,Deo, S.V.S., Shukla, N.K., and Ralhan, R. (2007). MGMT expression in oral precancerous and cancerous lesions: correlationwith progression, nodal metastasis and poor prognosis. Oral Oncol 43, 515-522. (Pubitemid 46561437)
27. Shan, S.W., Tang,M.K., Chow, P.H.,Maroto,M., Cai, D.Q., and Lee, K.K.H. (2007). Induction of growth arrest and polycomb gene expression by reversine allows C2C12 cells to be reprogrammed to various differentiated cell types. Proteomics 7, 4303-4316. (Pubitemid 350250475)
28. Shen, Z.Y., Xu, L.Y., Chen, M.H., Li, E.M., Li, J.T., Wu, X.Y., and Zeng, Y. (2003). Upregulated expression of Ezrin and invasive phenotype in malignantly transformed esophageal epithelial cells. World J Gastroenterol 9, 1182-1186. (Pubitemid 36805648)
29. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996). Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68, 850-858.
30. Silber, J.R., Mueller, B.A., Ewers, T.G., and Berger, M.S. (1993).Comparison of O6-Methylguanine-DNA Methyltransferase.
31. Nakasu, S., Fukami, T., Jito, J., and Matsuda, M. (2007). Prognostic significance of loss of O6-methylguanine-DNA methyltransferase expression in supratentorial diffuse low-grade astrocytoma. Surg Neurol 68, 603-609.
32. Ohgaki, H., Hard, G.C., Hirota, N., Maekawa, A., Takahashi, M., and Kleihues, P.(1992). Selective mutation of codons 204 and 213 of the p53 gene in rat tumors induced by alkylating N-nitroso compounds. Cancer Res 52, 2995-2998.
33. Oh, K., Redston, M., and Odze, R.D. (2005) Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol 36, 101-111. (Pubitemid 40215639)
34. Olsson, M., and Lindahl, T. (1980). Repair of Alkylated DNA in Escherichia coli: methyl group transfer from O6-methylguanine to a protein cysteine residue. J Biol Chem 255, 10569-10571. (Pubitemid 11171712)
35. Sawhney,M., Rohatgi,N., Kaur, J.,Gupta, S.D.,Deo, S.V.S., Shukla, N.K., and Ralhan, R. (2007). MGMT expression in oral precancerous and cancerous lesions: correlationwith progression, nodal metastasis and poor prognosis. Oral Oncol 43, 515-522. (Pubitemid 46561437)
36. Shan, S.W., Tang,M.K., Chow, P.H.,Maroto,M., Cai, D.Q., and Lee, K.K.H. (2007). Induction of growth arrest and polycomb gene expression by reversine allows C2C12 cells to be reprogrammed to various differentiated cell types. Proteomics 7, 4303-4316. (Pubitemid 350250475)
37. Shen, Z.Y., Xu, L.Y., Chen, M.H., Li, E.M., Li, J.T., Wu, X.Y., and Zeng, Y. (2003). Upregulated expression of Ezrin and invasive phenotype in malignantly transformed esophageal epithelial cells. World J Gastroenterol 9, 1182-1186. (Pubitemid 36805648)
38. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M.(1996). Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels Anal Chem 68, 850-858.
39. Silber, J.R., Mueller, B.A., Ewers, T.G., and Berger, M.S. (1993).Comparison of O6-Methylguanine-DNA Methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res 53, 3416-3420. (Pubitemid 23223319)
40. Thompson, C.C., Ashcroft, F.J., Patel, S., Saraga, G., Vimalachandran, D., Prime, W., Campbell, F., Dodson, A., Jenkins, A.E., Lemoine, N.R., Crnogorac-Jurcevic, T., Yin, H.R., and Costello, E. (2007). Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut 56, 95-106. (Pubitemid 46044895)
41. Tomayko, M.M., and Reynolds, C.P. (1989). Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemoth Pharm 24, 148-154. (Pubitemid 19163397)
42. Waldstein, E.A., (1990). Effect of O6-methylgeamme-DNA metlhyltirainisfferase gene activity on repair in human cells transformed by a regulatable ada gene. Carcinogenesis 11, 21-26. (Pubitemid 20050730)
43. Zhu, G., and Yu, Y.N. (2004). Enzyme activity analysis of CYP2C18 with exon 5 skipped. Acta Pharmacol Sin 25, 1065-1069.